CASI Pharmaceuticals, Inc (DE) Annual Revenues in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
CASI Pharmaceuticals, Inc (DE) quarterly/annual Revenues history and growth rate from 2010 to 2022.
  • CASI Pharmaceuticals, Inc (DE) Revenues for the quarter ending December 31, 2022 was $15.3M, a 66.6% increase year-over-year.
  • CASI Pharmaceuticals, Inc (DE) Revenues for the twelve months ending December 31, 2022 was $43.1M, a 42.9% increase year-over-year.
  • CASI Pharmaceuticals, Inc (DE) annual Revenues for 2022 was $43.1M, a 42.9% increase from 2021.
  • CASI Pharmaceuticals, Inc (DE) annual Revenues for 2021 was $30.2M, a 99.2% increase from 2020.
  • CASI Pharmaceuticals, Inc (DE) annual Revenues for 2020 was $15.1M, a 267% increase from 2019.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $43.1M +$12.9M +42.9% Jan 1, 2022 Dec 31, 2022 20-F 2023-04-26
2021 $30.2M +$15M +99.2% Jan 1, 2021 Dec 31, 2021 20-F 2023-04-26
2020 $15.1M +$11M +267% Jan 1, 2020 Dec 31, 2020 20-F 2023-04-26
2019 $4.13M +$4.13M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $0 Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2013 $0 -$669K -100% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-21
2012 $669K -$1.27M -65.5% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-21
2011 $1.94M -$1.75M -47.4% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-21
2010 $3.69M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.